Nicholas D E Greene Selected Research

Retinaldehyde (Retinal)

4/2002

Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas D E Greene Research Topics

Disease

38	Neural Tube Defects (Exencephaly) 09/2023 - 02/2002
9	Spinal Dysraphism (Spina Bifida) 01/2023 - 09/2002
5	Congenital Abnormalities (Deformity) 09/2021 - 09/2002
4	Nonketotic Hyperglycinemia 05/2024 - 03/2015
3	Epilepsy (Aura) 11/2020 - 04/2007
2	Fetal Alcohol Spectrum Disorders 01/2017 - 03/2015
2	Methylenetetrahydrofolate reductase deficiency 01/2017 - 03/2015
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 08/2013 - 02/2009
2	Spinal Cord Injuries (Spinal Cord Injury) 07/2011 - 05/2010
1	HIV Infections (HIV Infection) 09/2023
1	Weight Gain 01/2023
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020
1	Encephalocele (Encephalocele, Frontal) 11/2019
1	Hyperglycemia 01/2017
1	Hydrocephalus (Hydrocephaly) 03/2015
1	Liver Diseases (Liver Disease) 03/2015
1	Infertility (Sterility) 08/2013
1	Ciliopathies 08/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2013
1	Type 2 Diabetes Mellitus (MODY) 03/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2013
1	Anencephaly (Aprosencephaly) 01/2012
1	Pathologic Processes 05/2010
1	Status Epilepticus (Complex Partial Status Epilepticus) 04/2007
1	Blister (Bulla) 02/2003
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 04/2002

Drug/Important Bio-Agent (IBA)

26	Folic Acid (Vitamin M)FDA LinkGeneric 09/2023 - 02/2002
6	Inositol (Myoinositol)IBA 01/2021 - 09/2002
6	CarbonIBA 01/2020 - 05/2006
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 04/2007
3	glycine cleavage systemIBA 05/2024 - 04/2012
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2024 - 03/2015
3	Glycine Dehydrogenase (Decarboxylating)IBA 01/2021 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2012
2	dolutegravirIBA 09/2023 - 01/2023
2	Methionine (L-Methionine)FDA Link 01/2020 - 05/2006
2	NucleotidesIBA 07/2016 - 09/2013
1	Actins (F Actin)IBA 01/2023
1	Ephrin-B1 (Ephrin B1)IBA 01/2022
1	GlycosaminoglycansIBA 01/2022
1	EphrinsIBA 01/2022
1	Tobacco Smoke Pollution (Passive Smoking)IBA 09/2021
1	Aminomethyltransferase (Glycine Synthase)IBA 01/2021
1	IntegrinsIBA 10/2020
1	CannabidiolIBA 01/2020
1	Monomeric GTP-Binding ProteinsIBA 11/2019
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2019
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	Choline (Choline Chloride)IBA 01/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017
1	Phosphorylcholine (Phosphocholine)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	ClaudinsIBA 01/2017
1	formic acid (formate)IBA 07/2016
1	S-AdenosylhomocysteineIBA 03/2015
1	5-methyltetrahydrofolateIBA 03/2015
1	purineIBA 09/2013
1	pyrimidineIBA 09/2013
1	Dyneins (Dynein)IBA 08/2013
1	ElementsIBA 08/2013
1	Metformin (Glucophage)FDA LinkGeneric 03/2013
1	BiguanidesIBA 03/2013
1	MicroRNAs (MicroRNA)IBA 08/2012
1	Lamin Type B (Lamin B)IBA 01/2012
1	CalciumIBA 07/2011
1	Calcium Chelating AgentsIBA 07/2011
1	Semaphorin-3AIBA 05/2010
1	EphA7 ReceptorIBA 01/2009
1	GPI-Linked ProteinsIBA 01/2009
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2009
1	Transcription Factors (Transcription Factor)IBA 11/2007
1	LithiumIBA 04/2007
1	Pilocarpine (Ocusert)FDA LinkGeneric 04/2007
1	ProteomeIBA 04/2007
1	rho-Associated KinasesIBA 02/2007
1	CycloleucineIBA 07/2006
1	EthionineIBA 07/2006
1	Protein Isoforms (Isoforms)IBA 01/2004
1	Protein Kinase CIBA 01/2004
1	homocysteine thiolactoneIBA 02/2003
1	HomocysteineIBA 02/2003
1	CarbohydratesIBA 04/2002
1	Retinaldehyde (Retinal)IBA 04/2002

Therapy/Procedure

1	Therapeutics 10/2003